§ Blog · Stock move

Why UnitedHealth (UNH) Stock Fell 10.2% on November 18

UnitedHealth (UNH) dropped 10.2% on November 18. We cover the move, technicals, valuation, and what's next for investors.

Thastock Research · November 19, 2026 · 3 min read
November 18 move
-10.2%
November 18 close
$349.91
30 days
-16.5%
RSI (14)
24
P/E
28.3
52-week position
51%
TL;DR
  • UNH stock fell 10.2% on November 18, closing at $349.91.
  • No clear news catalyst was reported for the drop.
  • The stock is now oversold with an RSI of 24.
  • Analysts remain positive, with 27 buys and no sells.

In this post: UNH forecast

What Happened to UnitedHealth Stock on November 18?

UnitedHealth Group (UNH) shares dropped 10.2% on November 18, closing the session at $349.91. This was a significant single-day move for the stock.

There was no specific news headline on November 18 directly explaining the sharp decline. Sometimes, stocks can move on market sentiment or sector trends even without a clear company-specific event.

A 10.2% drop in one session is notable for a large company like UnitedHealth, so investors may want to review their risk tolerance and stay updated on news.

Was There a Catalyst for the Decline?

No major news or company announcement was reported on November 18 that would directly explain the 10.2% drop. The available headlines from the period discuss industry outlooks and comparisons to peers, but do not mention any specific event affecting UnitedHealth that day.

Examples of headlines include industry outlooks and articles comparing UnitedHealth to other healthcare companies, but none cite a direct reason for the sudden decline.

When a stock moves sharply without a clear catalyst, it may be due to broader market factors, sector rotation, or investor sentiment rather than company-specific news.

See the full AI bull vs bear case on UNH →Free, about 10 seconds.

Technical Picture: Trend, RSI, and 52-Week Range

UNH closed at $349.91, which is 51% of its 52-week range between $259.02 and $436.35. This means the stock is trading near the middle of its yearly range.

The 50-day moving average is $390.64, and the 200-day moving average is $367.91. The current price is below both averages, which signals a downward trend.

The RSI (Relative Strength Index) is 24, which is below 30 and considered oversold. An oversold RSI can indicate the stock has fallen quickly and may be due for a pause or rebound, but it is not a guarantee.

Over the past 30 days, UNH is down 16.5%, and over 90 days, it is down 9.1%. Despite recent declines, it is still up 13.2% over the past year.

Valuation and Analyst Sentiment

UnitedHealth's price-to-earnings (PE) ratio is 28.3. This means investors are paying $28.30 for every $1 of earnings, which can be compared to peers or the broader market for context.

Analyst sentiment remains positive, with 27 analysts rating the stock a buy, 5 rating it a hold, and none rating it a sell as of the latest period. This suggests that most analysts are optimistic about the company's outlook.

Over the last four quarters, UnitedHealth beat earnings estimates three times, with an average surprise of 12.3%. Consistent earnings beats can indicate strong management and business performance.

Valuation and analyst ratings are important for investors to gauge market expectations and confidence in the company.

What to Watch Next for UnitedHealth

The next scheduled earnings report is on January 25, with an earnings-per-share (EPS) estimate of $2.29. Earnings announcements often move the stock, especially if results differ from expectations.

Investors should watch for any new company news or industry developments that could impact UnitedHealth's business or stock performance.

Given the oversold RSI and recent sharp decline, some investors may monitor for signs of stabilization or a potential rebound, but technical indicators are not guarantees.

Staying aware of analyst updates and future earnings results can help investors make informed decisions.

FAQ

Why did UnitedHealth stock fall so much on November 18?

There was no clear news or company event explaining the 10.2% drop on November 18. Sometimes, stocks move sharply due to market sentiment or sector trends even without a specific catalyst.

Is UnitedHealth oversold after this decline?

Yes, the RSI is 24, which is below 30 and considered oversold. This means the stock has dropped quickly, but an oversold reading does not guarantee a rebound.

What is the next key date for UnitedHealth investors?

The next key date is January 25, when UnitedHealth is scheduled to report earnings. The EPS estimate for that quarter is $2.29, and earnings results can impact the stock price.

Get moves like this before they're news.

Set price and RSI alerts on UNH and get an email or push the moment they trigger. Free plan forever; new accounts get 7 days of Pro.

Start free →
Sources
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina · Zacks Investment Research
UnitedHealth Keeps Raising Guidance. Here's What a $10,000 Investment Could Be Worth if the Turnaround Sticks. · The Motley Fool
UnitedHealth (UNH) vs. Humana (HUM): Buy the Dip? · Zacks Investment Research
Is UnitedHealth Group (UNH) Stock Outpacing Its Medical Peers This Year? · Zacks Investment Research

Written by Thastock Research with AI assistance from live market data, and automatically checked against that data before publishing. Educational only, not financial advice.

MORE FROM THE BLOG
Why Advanced Micro Devices (AMD) Stock Fell 7.7% on November 19Why Salesforce (CRM) Stock Fell 9.5% on November 17Why Micron (MU) Stock Fell 7.6% on November 16